Arabic Arabic English English French French German German
dark

VastBiome Announces Large Exploratory Prospective Data Collection to Understand Basic Science of the Microbiome and Immune Checkpoint Inhibitor Therapy

VastBiome is announcing sponsorship of an observational clinical study designed to collect data to understand molecular associations between immune checkpoint inhibitor (ICI) therapy and the gut microbiome (the collection of bacteria and other bugs living in the gastrointestinal tract). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Wolters Kluwer Launches Workflow Solution to Support Evidence-Based Practice

Next Post

Global Rare Disease Drug Market Size Clinical Trials Insight 2028

Related Posts
Total
0
Share